| CAS NO: | 1588870-36-3 |
| 包装 | 价格(元) |
| 10 mM * 1 mL in DMSO | 电议 |
| 5mg | 电议 |
| 10mg | 电议 |
| 25mg | 电议 |
| 50mg | 电议 |
| 100mg | 电议 |
| 200mg | 电议 |
| 500mg | 电议 |
| 生物活性 | Tankyrase-IN-2 (compound 5k) is a potent, selective, and orally activetankyraseinhibitor (IC50s of 10, 7, and 710 nM for TNKS1, TNKS2 as well asPARP1, respectively). Tankyrase-IN-2 has favorable physicochemical profile and pharmacokinetic properties modulatingWntpathway activity in a colorectal xenograft model[1]. | ||||||||||||||||
| IC50& Target | IC50: 10 nM (TNKS1), 7 nM (TNKS2), 710 nM (PARP1)[1] | ||||||||||||||||
| 体外研究 (In Vitro) | Tankyrase-IN-2 (1-10000 nM; 24 hours) leads to a dose-dependent increase of tankyrase protein abundance with an EC50of 320 nM in DLD1 cells. This is in the same potency range as the value for axin2 increase (EC50=319 nM)[1]. | ||||||||||||||||
| 分子量 | 316.30 | ||||||||||||||||
| 性状 | Solid | ||||||||||||||||
| Formula | C17H14F2N2O2 | ||||||||||||||||
| CAS 号 | 1588870-36-3 | ||||||||||||||||
| 运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||||||||||
| 储存方式 |
| ||||||||||||||||
| 溶解性数据 | In Vitro: DMSO : 83.33 mg/mL(263.45 mM;Need ultrasonic) 配制储备液
* 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 In Vivo: 请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照In Vitro方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用;
以下溶剂前显示的百
*以上所有助溶剂都可在本网站选购。 |
